Advancing primary care with essential peer-reviewed research and insights into CNS disorders
Page 14
More Articles from The Primary Care Companion for DNS Disorders
Narrative Review
Incretin Therapies: A New Tool to Combat Metabolic Consequences of Antipsychotic Use
September 4, 2025
Incretin therapies have emerged as a promising treatment option with potential benefits for mitigating cardiometabolic side effects associated with antipsychotics; however, clinical trials have often excluded psychiatric populations.